Cargando…
Novel Mutations in the DGKE Gene in Two Indian Patients with Early-onset Atypical Haemolytic Uraemic Syndrome
Atypical haemolytic uremic syndrome (aHUS) is a clinically and genetically heterogeneous condition caused by a complex interplay between genomic susceptibility factors and environmental influences. Pathogenic variants in the DGKE gene are recently identified in cases with infantile-onset autosomal r...
Autores principales: | Sharma, Jyoti, Lobo, Valentine, Singhal, Jyoti, Anand, Siddharth, Kadam, Sandeep, Ranade, Shatakshi, Gangodkar, Priyanka, Ganesan, Karthik, Phadke, Nikhil, Agarwal, Meenal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240919/ https://www.ncbi.nlm.nih.gov/pubmed/34267444 http://dx.doi.org/10.4103/ijn.IJN_336_19 |
Ejemplares similares
-
Eculizumab in secondary atypical haemolytic uraemic syndrome
por: Cavero, Teresa, et al.
Publicado: (2017) -
A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report
por: Alabdulqader, Muneera, et al.
Publicado: (2021) -
Early treatment with eculizumab in atypical haemolytic uraemic syndrome
por: Garjau, Maria, et al.
Publicado: (2012) -
Ravulizumab: A Review in Atypical Haemolytic Uraemic Syndrome
por: Syed, Yahiya Y.
Publicado: (2021) -
Recent advances in diagnosis and treatment of atypical haemolytic uraemic syndrome
por: Bolton-Maggs, Paula HB
Publicado: (2010)